Logo image
Prof. Dr. med. Michael Thomas working place, University Hospital Heidelberg
Prof. Dr. med. Michael Thomas
Excellent
AiroScore
9.90

Prof. Dr. med. Michael Thomas

internal medicine, oncology, and pneumology
internal medicine, oncology, and pneumology
User ScoreExperienceRatingPrice RangePublicationsOnline Consultations
94%39 years9.9/10$$$$5913No

Overview

Country, City
Germany, Heidelberg
Health facility
University Hospital Heidelberg
Medical unit
Department of thoracic oncology

About the doctor

Prof. Dr. med. Michael Thomas is a highly experienced doctor with 38 years of experience in internal medicine, oncology, and pneumology. He works at the Department of thoracic oncology at the University Hospital Heidelberg in Germany. Dr. Thomas has an impressive educational background, including a doctorate in "High-frequency jet ventilation - optimization in animal models" and a habilitation in "Oncoprotein detection and therapy optimization". He has obtained multiple specializations, such as internal medicine, hematology and oncology, pneumology, and palliative medicine. Dr. Thomas has made significant contributions to his field, with many scientific publications, including studies on lung cancer, neoadjuvant immunotherapy, and multimodal therapy for pleural mesothelioma. He has also been involved in various professional organizations and awarded several prizes for his work, including the Science Prize of the German Cancer Society and the John Mendelsohn Study Award. Dr. Thomas is considered a leader in his field with his extensive knowledge and expertise and his dedication to research and patient care. His focus on lung cancer and his involvement in clinical research make him a valuable asset to the medical community. Patients can trust that they are in good hands under his care at the University Hospital Heidelberg's Department of thoracic oncology.

Skills & Expertise

cancer
lung
lung cancer
children
covid19
injury
asthma
cell lung cancer
infection
kidney
breast
heart
cardiac arrest
liver
fibrosis
tumor
colorectal cancer
carcinoma
chemotherapy
nonsmallcell lung cancer
bone
breast cancer
heart failure
oncology
prostate cancer
metastases
cell carcinoma
lung adenocarcinoma
staphylococcus aureus
rectal cancer
malignant
squamous cell carcinoma
internal medicine
lymph node
pulmonary fibrosis
lung function
oesophageal cancer
pancreatic cancer
colon cancer
bowel cancer
lung carcinoma
pulmonary function
pulmonary hypertension
lung tumors
pneumology
neuroendocrine lung carcinoma
biliary tract cancer
head neck cancer
renal cell carcinoma
pulmonological oncology

Resume

CV (Curriculum Vitae)

Education
  • 1979-1985 Studied human medicine at the University of Giessen
  • Obtaining a license for medical practice
  • Doctorate at the University of Giessen: "High-frequency jet ventilation - optimization in animal models"
  • 1992 Obtaining specialization in internal medicine
  • 1994 Received additional qualification in the field of hematology and oncology
  • 1996 Obtaining further specialization in pneumology
  • 1996 Additional designation as a senior emergency doctor
  • 1997 Habilitation at the University of Munster: "Oncoprotein detection and therapy optimization"
  • 2000 Additional designation special internal intensive care medicine
  • 2006 Received additional qualification in the field of palliative medicine
Experience
  • 1986-1987 Assistant Doctor, Evangilish Giessen Hospital
  • 1987-1992 Assistant Doctor, University Hospital Duesseldorf
  • 1992-1996 Assistant Doctor, University Hospital Muenster
  • 1996-2005 Senior Physician, University Hospital Muenster
  • 2000 Visiting Professor of the Department of pulmonology at the University of Pennsylvania
  • 2004 C3 Professorship for internal medicine/pneumology, University Hospital Muenster
  • 2005 W3 Professorship, Chief Physician, Department of thoracic oncology, University Hospital Heidelberg
  • 2015 Professorship, Department of thoracic oncology, University Hospital Heidelberg
Awards & Memberships
  • 1995-2003 Coordination of the German Lung Cancer Cooperative Group: “Multicentric study group - multimodal therapy context”
  • 1997-2005 Speaker of the pulmonological oncology section of the German Society for Pneumology
  • 2002 Science Prize of the working group on internal oncology at the German Cancer Society
  • 2010 John Mendelsohn Study Award of the German Cancer Society
  • 2010-2016 Spokesman for the working group on pulmonological oncology at the German Cancer Society
  • 2011 Spokesman for the disease area “Lung cancer” in the German Center for Lung Research of the Federal Ministry of Education and Research-funded "Health centers"
  • 2015 Deputy Spokesman on the steering board of the Cross Registry Information Service Protocol registry: “Clinical research into molecular testing, treatment and outcome of non-small-cell lung cancer patients”
  • 2016 Member of the board of the working group for internal oncology in the German Cancer Society
  • 2019-2022 Spokesman for the Lung Cancer Control Group of the AIO in the German Cancer Society
  • Member of the International Association on the Study of Lung Cancer
  • Member of the European Society of Medical Oncology
  • Member of the American Society of Clinical Oncology
  • Member of the European Respiratory Society
  • Member of the German Society for Hematology and Oncology
  • Member of the German Cancer Society
  • Member of the German Society for Pneumology

Languages

English flag
English
German flag
German

Publications

Investigation on removal of perfluorooctanoic acid (PFOA), perfluorooctane sulfonate (PFOS), perfluorohexane sulfonate (PFHxS) using water treatment sludge and biochar.

October, 2023

Rationale and Design of the Phase II ANTELOPE Study of Atezolizumab, Carboplatin and nab-Paclitaxel vs. Pembrolizumab, Platinum and Pemetrexed in TTF-1 Negative, Metastatic Lung Adenocarcinoma (AIO-TRK-0122).

September, 2023

Real-world data for precision cancer medicine-A European perspective.

September, 2023

Location

Im Neuenheimer Feld, 672, 69120 Heidelberg, Germany

FAQ

Where does the doctor practice?

What is the specialization of Prof. Dr. med. Michael Thomas?

The primary specialization of the doctor is internal medicine, oncology, and pneumology.

What is the experience of the specialist?

Prof. Dr. med. Michael Thomas has been practicing for more than 39 years.

What is the rating of the doctor?

What topics does Prof. Dr. med. Michael Thomas expert at?

The doctor has excellent knowledge in cancer, lung, lung cancer, children, covid19.

Is the specialist involved in the research?

Does the specialist offer online consultations?

No, Prof. Dr. med. Michael Thomas doesn’t perform virtual appointments.

Prof. Dr. med. Michael Thomas
Prof. Dr. med. Michael Thomas

Get individual treatment plan and cost estimate. Non-binding 100% free assessment.

© Prof. Dr. med. Michael Thomas

Similar Doctors

Prof. Dr. med. Bernd Alt-Epping
Excellent
AiroScore
9.90
University Hospital Heidelberg
internal, palliative and emergency medicine, hematology, oncology, pain therapy
Prof. Dr. med. Andreas Kulozik, Ph.D.
Excellent
AiroScore
9.90
University Hospital Heidelberg
pediatrics, pediatric hematology and oncology, pulmonology, and immunology
Prof. Dr. med. Birgit Friedmann-Bette
Excellent
AiroScore
9.90
University Hospital Heidelberg
internal and sports medicine, physical therapy and balneology
Prof. Dr. med. Dirk Jager
Excellent
AiroScore
9.90
University Hospital Heidelberg
internal medicine, hematology, and oncology
Prof. Dr. med. Carsten Muller-Tidow
Excellent
AiroScore
9.90
University Hospital Heidelberg
internal medicine, hematology, oncology, and rheumatology
Prof. Dr. med. Norbert Frey
Excellent
AiroScore
9.90
University Hospital Heidelberg
internal medicine, pulmonology and cardiology
Prof. Dr. med. Felix Herth
Excellent
AiroScore
9.90
University Hospital Heidelberg
internal medicine, pneumology, and respiratory medicine
Prof. Dr. med. Uta Merle
Excellent
AiroScore
9.90
University Hospital Heidelberg
internal medicine, gastroenterology, and poisoning medicine
Prof. Dr. Julia Szendrodi, Ph.D.
Excellent
AiroScore
9.90